Reduced nitric oxide responsive soluble guanylyl cyclase activity in the superior temporal cortex of patients with Alzheimer's disease.
Particulate and soluble guanylyl cyclase activities were studied in postmortem temporal cortex from a series of Alzheimer's disease patients and matched control subjects. Particulate guanylyl cyclase activity was not significantly different between groups. In contrast, the Vmax values for basal and sodium nitroprusside-stimulated soluble guanylyl cyclase activities were approximately 50% lower in the Alzheimer's disease cases, compared to controls. This difference between groups was statistically significant for sodium nitroprusside-stimulated, but not for the basal, enzyme activities. These results provide the first evidence for a loss of nitric oxide responsive guanylyl cyclase activity in Alzheimer's disease brain.
Bonkale
W L
WL
Karolinska Institute, Department of Clinical Neuroscience and Family Medicine, Huddinge, Sweden.
Winblad
B
B
Ravid
R
R
Cowburn
R F
RF
D000368:Aged; D000544:Alzheimer Disease / Q000378:metabolism*; D001344:Autopsy; D006152:Cyclic GMP / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006162:Guanylate Cyclase / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D008274:Magnesium / Q000494:pharmacology; D009569:Nitric Oxide / Q000378:metabolism*; D013702:Temporal Lobe / Q000378:metabolism*
D009569:Nitric Oxide; D006162:Guanylate Cyclase; D006152:Cyclic GMP; D008274:Magnesium